Pancreatic Cancer Research

ResearcherCentre National de la Recherche ScientifiqueActive in the last 2 years

Julie Guillermet‐Guibert

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-3173-4907; OpenAlex author ID A5031663089. Sources: OpenAlex.

Their work

Papers
15 (first author 2, last author 10)
Trials
0
Grants
0
Labs led
1
Collaborators
31
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: 2 papers · 2019: 2 papers · 2020: none · 2021: 4 papers · 2022: 1 paper · 2023: none · 2024: none · 2025: 3 papers

Papers 15

  1. Biotechnological advances in 3D modeling of cancer initiation. Examples from pancreatic cancer research and beyond. Last author DOI 10.1088/1758-5090/adb51c↗
  2. Mechanical compressive forces increase PI3K output signaling in breast and pancreatic cancer cells. Last author DOI 10.26508/lsa.202402854↗
  3. Formation and Characterization of Two Magnetic Three-Dimensional Spheroid Models of Murine Pancreatic Adenocarcinoma. Co-author DOI 10.3390/mps8040075↗
  4. Upregulated Apelin Signaling in Pancreatic Cancer Activates Oncogenic Signaling Pathways to Promote Tumor Development. Co-author DOI 10.3390/ijms231810600↗
  5. The type of KRAS mutation drives PI3Kα/γ signalling dependency: Implication for the choice of targeted therapy in pancreatic adenocarcinoma patients. First author DOI 10.1016/j.clinre.2020.05.021↗
  6. Is targeting autophagy a promising lead to unveil the cloak of invisibility in pancreatic cancer? Last author DOI 10.1016/j.clinre.2021.101622↗
  7. Phosphoproteomics Identifies PI3K Inhibitor-selective Adaptive Responses in Pancreatic Cancer Cell Therapy and Resistance. Last author DOI 10.1158/1535-7163.mct-20-0981↗
  8. Pancreatic cancer intrinsic PI3Kα activity accelerates metastasis and rewires macrophage component. Last author DOI 10.15252/emmm.202013502↗
  9. eIF4A inhibition circumvents uncontrolled DNA replication mediated by 4E-BP1 loss in pancreatic cancer. Co-author DOI 10.1172/jci.insight.121951↗
  10. Experimental pancreatic cancer develops in soft pancreas: novel leads for an individualized diagnosis by ultrafast elasticity imaging. Last author DOI 10.7150/thno.34066↗
  11. Opportunities and Resistance to Signal-targeted Therapies in Pancreatic Cancer: What Can We Learn from Proteomic Studies? Last author DOI 10.20944/preprints201802.0011.v1↗
  12. Signal-Targeted Therapies and Resistance Mechanisms in Pancreatic Cancer: Future Developments Reside in Proteomics. Last author DOI 10.3390/cancers10060174↗
  13. Attenuating PI3K isoforms in pancreatic cancer: Focus on immune PI3Kγ. First author DOI 10.1016/j.clinre.2017.04.013↗
  14. Implication of PI3K/Akt pathway in pancreatic cancer: When PI3K isoforms matter? Last author DOI 10.1016/j.jbior.2015.05.001↗
  15. Increase in PI3K signalling mimics mutated-Kras induction of pancreatic cancer Last author DOI 10.1016/j.clinre.2013.04.006↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Nicole Therville · 6 shared papers, 2015–2025 · strength 0.70
  2. Coralie Cayron · 4 shared papers, 2021 · strength 0.70
  3. Benoît Thibault · 4 shared papers, 2018–2025 · strength 0.53
  4. Célia Cintas · 5 shared papers, 2015–2021 · strength 0.49
  5. Céline Basset · 4 shared papers, 2017–2021 · strength 0.43
  6. Romain Baer · 4 shared papers, 2013–2021 · strength 0.30
  7. Maxime Lafond · 1 shared paper, 2025 · strength 0.28
  8. Cyril Lafon · 1 shared paper, 2025 · strength 0.28
  9. Magali Perier · 1 shared paper, 2025 · strength 0.28
  10. Charles Handschin · 1 shared paper, 2025 · strength 0.27
  11. Mickaël Di‐Luoffo · 1 shared paper, 2025 · strength 0.25
  12. Pierre Cordelier · 2 shared papers, 2021–2022 · strength 0.21
  13. Stéphane Pyronnet · 2 shared papers, 2013–2019 · strength 0.14
  14. Carline Chaves-Almagro · 1 shared paper, 2022 · strength 0.12
  15. Bernard Masri · 1 shared paper, 2022 · strength 0.12
  16. Audrey Francès · 1 shared paper, 2022 · strength 0.12
  17. Zahra Dantes · 1 shared paper, 2021 · strength 0.10
  18. Paola Cappello · 1 shared paper, 2021 · strength 0.10
  19. Maximilian Reichert · 1 shared paper, 2021 · strength 0.10
  20. Fabrice Muscari · 1 shared paper, 2021 · strength 0.09
  21. Chiara Falcomatà · 1 shared paper, 2021 · strength 0.09
  22. Gabriela Reyes‐Castellanos · 1 shared paper, 2021 · strength 0.09
  23. Barbara Bournet · 1 shared paper, 2021 · strength 0.09
  24. Alice Carrier · 1 shared paper, 2021 · strength 0.09
  25. Dieter Saur · 1 shared paper, 2021 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.